Changes in blood serotonin during hemodialysis

Area of Science:

• Nephrology
• Hematology
• Biochemistry

Background:

• Uremia is associated with clotting disorders.
• Serotonin (5-hydroxytryptamine) is implicated in hemostasis.
• The role of serotonin in renal failure requires further investigation.

Purpose of the Study:

• To investigate serotonin levels in patients with severe renal failure.
• To examine the effect of dialysis on blood serotonin concentrations.
• To explore the correlation between serotonin changes and uremic complications.

Main Methods:

• Blood samples were collected from patients with acute and chronic renal failure.
• Serotonin levels in plasma and platelets were measured.
• Patients underwent regular dialysis treatment, with serotonin levels monitored pre- and post-dialysis.
• Electrolytes and other laboratory parameters were analyzed.

Main Results:

• Patients with severe renal failure exhibited elevated blood serotonin levels.
• Serotonin concentrations increased in the blood following each dialysis session.
• Platelet counts remained stable during hemodialysis.
• Correlations were observed between serotonin levels and electrolyte balance.

Conclusions:

• Increased blood serotonin is a feature of severe renal failure.
• Dialysis treatment leads to a rise in blood serotonin.
• These serotonin level alterations may contribute to the hemostatic disturbances seen in uremia.